Canadian Transient Ischemic Attack (TIA) Score

ورودی‌های بالینی بیمار

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
canadian tia score
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Low Risk-3–3
  • Medium Risk4–8
  • High Risk9–23
Direct Clinical Answer

The Canadian Transient Ischemic Attack (TIA) Score calculates quantifying neurological deficit severity, stroke volume, and reperfusion therapy eligibility. Key inputs include first tia lifetime. Scores guide initiating intravenous thrombolysis, activating endovascular thrombectomy pathways, or secondary prevention protocols. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

The Canadian TIA Score identifies risk of stroke, carotid endarterectomy, or carotid artery stenting within 7 days in patients who experienced TIA symptoms. It incorporates 13 predictive variables from history, physical examination, and testing routinely performed in the emergency department.

Clinical Indication

The Canadian Transient Ischemic Attack (TIA) Score is indicated for bedside clinical practice to support The Canadian TIA Score identifies risk of stroke, carotid endarterectomy, or carotid artery stenting within 7 days in patients who experienced TIA symptoms. It incorporates 13 predictive variables from history, physical examination, and testing routinely performed in the emergency department.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with acute neurological deficits, acute ischemic stroke, intracranial hemorrhage, seizures, or altered mental status. Clinical application is indicated across Comprehensive stroke centers, acute neurovascular units, neuro-ICU, and emergency neurology services.

Limitations & Contraindications

Stroke mimics including severe hypoglycemia, Todd postictal paresis, and hemiplegic migraine must be ruled out prior to intravenous thrombolysis.

Clinical Pearls & Action Plan

Time is brain; rapid determination of Last Known Well time and baseline functional status dictates reperfusion eligibility. Guideline pearl: Based on prospective validation in 8,355 patients across multiple centers.

Formula & Variables:

Score = (2 × first_tia_lifetime) + (2 × symptoms_ten_minutes) + (2 × history_carotid_stenosis) + (3 × on_antiplatelet_therapy) + (1 × history_gait_disturbance) + (1 × history_unilateral_weakness) + (-3 × history_vertigo) + (3 × diastolic_bp_110) + (1 × dysarthria_aphasia) + (2 × atrial_fibrillation_ecg) + (1 × infarction_on_ct) + (2 × platelet_count_400) + (3 × glucose_15_mmol)

Input Parameters

NameTypeRequiredDescription
first_tia_lifetimestringYesFirst TIA episode in patient's lifetime
symptoms_ten_minutesstringYesTIA symptoms lasted 10 minutes or longer
history_carotid_stenosisstringYesKnown history of carotid artery stenosis
on_antiplatelet_therapystringYesPatient already on antiplatelet therapy at time of TIA
history_gait_disturbancestringYesHistory of gait disturbance during the TIA episode
history_unilateral_weaknessstringYesHistory of unilateral weakness during the TIA episode
history_vertigostringYesHistory of vertigo during the TIA episode
diastolic_bp_110stringYesInitial triage diastolic blood pressure ≥110 mmHg
dysarthria_aphasiastringYesPresence of dysarthria or aphasia during the TIA episode
atrial_fibrillation_ecgstringYesAtrial fibrillation detected on ECG in the emergency department
infarction_on_ctstringYesAcute infarction visible on CT scan
platelet_count_400stringYesPlatelet count ≥400×10⁹/L
glucose_15_mmolstringYesBlood glucose ≥15 mmol/L (270 mg/dL)

Score Interpretation & Guidance

RangeStageDescription
-3–3Low Risk0.01-0.5% risk of stroke/intervention within 7 days
4–8Medium Risk1-5% risk of stroke/intervention within 7 days
9–23High Risk5.9-27.6% risk of stroke/intervention within 7 days

Evidence-Based References (EBM)

  • Perry JJ, Sharma M, Sivilotti ML, Sutherland J, Symington C, Worster A, et al. Prospective validation of the ABCD2 score for patients in the emergency department with transient ischemic attack. CMAJ. 2011 Jul 12;183(10):1137-45. doi: 10.1503/cmaj.101668.DOI: 10.1503/cmaj.101668
  • Perry JJ, Sivilotti ML, Sutherland J, Hohl CM, Émond M, Calder LA, et al. Validation of the Ottawa Subarachnoid Hemorrhage Rule in patients with acute headache. CMAJ. 2013 Nov 19;185(17):E805-12. doi: 10.1503/cmaj.121745.DOI: 10.1503/cmaj.121745
  • Perry JJ, Sharma M, Sivilotti ML, Sutherland J, Worster A, Émond M, et al. A prospective cohort study of patients with transient ischemic attack to identify high-risk clinical characteristics. Stroke. 2014 Jan;45(1):92-100. doi: 10.1161/STROKEAHA.113.003085.DOI: 10.1161/STROKEAHA.113.003085

Related calculators